Article Information
- Received June 24, 1996
- Revision received July 30, 1996
- Accepted August 6, 1996
- First published November 1, 1996.
- Version of record published November 1, 1996.
Author Information
Author contributions
Disclosures
- Received June 24, 1996.
- Revision received July 30, 1996.
- Accepted August 6, 1996.
↵FNa These authors contributed equally to this work.
We thank Dr. Peter Seeburg for CMV expression plasmids encoding wild-type GluRAi, GluRAo, and GFP; Dr. Stefano Vicini for technical advice; Dr. Robert Wenthold for GluR1 antibodies; Dr. Zhaolan Lin for advice with structural modeling; Dr. Patrick O’Hara for providing model coordinates; and Dr. Morris Benveniste for scientific discussions. Cyclothiazide was a gift from Lilly Research Laboratories (Indianapolis, IN), and aniracetam was a gift from Hoffmann-La Roche (Basel, Switzerland).
Correspondence should be addressed to Dr. Mark L. Mayer, LCMN/NICHD/National Institutes of Health, Building 49/Room 5A78, 49 Convent Drive MSC 4495, Bethesda, MD 20892-4495.
Dr. Partin’s present address: Department of Anatomy and Neurobiology, Colorado State University, Fort Collins, CO 80523-1670.
Online Impact